Home › Funds › Birchview Capital, LP › STOK
Birchview Capital, LP position in STOK
STOKE THERAPEUTICS INC · Health Care
Birchview Capital, LP reported holding 138,000 shares of STOK (STOKE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 2.14% of its reported portfolio and ranking #12 among its reported holdings. Birchview Capital, LP has disclosed STOK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Birchview Capital, LP's STOK position evolved
Birchview Capital, LP first disclosed a stake in STOK in Q3 2023 at 85,000 shares (US$335K). The position peaked in Q4 2025 at 260,000 shares, worth US$8.3M. Across 13 filings, Birchview Capital, LP increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 138,000 shares valued at US$3.6M — a reduction of -40,110 shares quarter over quarter.. Notable position changes include a 147% increase in Q4 2023 (shares rose 157% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 85.00K | $334.90K | New |
| Q4 2023 | 210.00K | $1.10M | Add |
| Q1 2024 | 210.00K | $2.83M | Hold |
| Q2 2024 | 210.00K | $2.84M | Hold |
| Q3 2024 | 210.00K | $2.58M | Hold |
| Q4 2024 | 210.00K | $2.32M | Hold |
| Q1 2025 | 210.00K | $1.40M | Hold |
| Q2 2025 | 210.00K | $2.38M | Hold |
| Q3 2025 | 210.00K | $4.93M | Hold |
| Q4 2025 | 260.00K | $8.25M | Add |
| Q1 2026 | 210.00K | $6.84M | Reduce |
| Q2 2026 | 178.11K | $5.83M | Reduce |
| Q3 2026 | 138.00K | $3.59M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About STOK and 13F data
STOK (STOKE THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$184.0M), Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STOK
- RTW INVESTMENTS, LP 5.62M sh · $184.00M · Q2 2026
- Lynx1 Capital Management LP 4.04M sh · $132.14M · Q2 2026
- Redmile Group, LLC 3.95M sh · $129.11M · Q2 2026
- BAKER BROS. ADVISORS LP 3.34M sh · $109.18M · Q2 2026
- TORONTO DOMINION BANK 3.17M sh · $103.83M · Q2 2026
- BVF INC/IL 2.55M sh · $83.36M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.82M sh · $59.66M · Q2 2026
- Siren, L.L.C. 2.00M sh · $51.88M · Q3 2026
- EcoR1 Capital, LLC 735.00K sh · $24.05M · Q2 2026
- MPM BioImpact LLC 723.31K sh · $23.67M · Q2 2026
- Opaleye Management Inc. 700.00K sh · $22.90M · Q2 2026
- Troluce Capital Advisors LLC 496.42K sh · $16.24M · Q2 2026
More on Birchview Capital, LP
FAQ
How long has Birchview Capital, LP held STOK?
Birchview Capital, LP has disclosed STOK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Birchview Capital, LP's current position in STOK?
As of Q3 2026, Birchview Capital, LP holds 138.00K shares of STOK (STOKE THERAPEUTICS INC), valued at $3.59M, representing 2.14% of its reported portfolio and ranking #12.
Has Birchview Capital, LP been buying or selling STOK?
In the latest 13F filing (Q3 2026), Birchview Capital, LP reduced its position in STOK. The position peaked in Q4 2025 at 260.00K shares.
Which other funds hold STOK?
Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.